Celtaxsys cystic fibrosis drug reduces key symptom in mid-stage study
By Tamara Mathias (Reuters) – Privately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did...
Read More